1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Kim, J.I. Konishi, S. Iwai, H. Kohno, T. Gouda, H. Shimada, I. Sato, K. Arata, Y. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 250 659 671 10.1006/jmbi.1995.0406 7623383 Three-dimensional solution structure of the calcium channel antagonist omega-agatoxin IVA: consensus molecular folding of calcium channel blockers. 1995 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 5220.393 OMEGA-AGATOXIN IVA 1 man polymer no no KKKCIAKDYGRCKWGGTPCCRGRGCICSIMGTNCECKPRLIMEGLGLA KKKCIAKDYGRCKWGGTPCCRGRGCICSIMGTNCECKPRLIMEGLGLA A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Agelenopsis sample 6908 Agelenopsis aperta pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_conf repository Initial release Version format compliance Version format compliance Derived calculations Other 1 0 1995-10-15 1 1 2008-03-24 1 2 2011-07-13 1 3 2017-11-29 _pdbx_database_status.process_site Y BNL 1995-06-28 REL 1 BRUNGER refinement X-PLOR 3.1 LYS 1 n 1 LYS 1 A LYS 2 n 2 LYS 2 A LYS 3 n 3 LYS 3 A CYS 4 n 4 CYS 4 A ILE 5 n 5 ILE 5 A ALA 6 n 6 ALA 6 A LYS 7 n 7 LYS 7 A ASP 8 n 8 ASP 8 A TYR 9 n 9 TYR 9 A GLY 10 n 10 GLY 10 A ARG 11 n 11 ARG 11 A CYS 12 n 12 CYS 12 A LYS 13 n 13 LYS 13 A TRP 14 n 14 TRP 14 A GLY 15 n 15 GLY 15 A GLY 16 n 16 GLY 16 A THR 17 n 17 THR 17 A PRO 18 n 18 PRO 18 A CYS 19 n 19 CYS 19 A CYS 20 n 20 CYS 20 A ARG 21 n 21 ARG 21 A GLY 22 n 22 GLY 22 A ARG 23 n 23 ARG 23 A GLY 24 n 24 GLY 24 A CYS 25 n 25 CYS 25 A ILE 26 n 26 ILE 26 A CYS 27 n 27 CYS 27 A SER 28 n 28 SER 28 A ILE 29 n 29 ILE 29 A MET 30 n 30 MET 30 A GLY 31 n 31 GLY 31 A THR 32 n 32 THR 32 A ASN 33 n 33 ASN 33 A CYS 34 n 34 CYS 34 A GLU 35 n 35 GLU 35 A CYS 36 n 36 CYS 36 A LYS 37 n 37 LYS 37 A PRO 38 n 38 PRO 38 A ARG 39 n 39 ARG 39 A LEU 40 n 40 LEU 40 A ILE 41 n 41 ILE 41 A MET 42 n 42 MET 42 A GLU 43 n 43 GLU 43 A GLY 44 n 44 GLY 44 A LEU 45 n 45 LEU 45 A GLY 46 n 46 GLY 46 A LEU 47 n 47 LEU 47 A ALA 48 n 48 ALA 48 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 1 A ARG 21 0.184 SIDE CHAIN 1 A ARG 23 0.304 SIDE CHAIN 1 A LYS 3 71.07 64.21 1 A PRO 18 -80.73 -151.78 1 A CYS 20 -87.56 -75.10 1 A ARG 21 -35.51 -29.49 1 A CYS 25 -66.57 87.25 1 A CYS 27 -107.15 -168.86 1 A SER 28 -88.12 30.93 1 A ILE 29 52.19 19.38 1 A ARG 39 28.84 98.90 model building X-PLOR refinement X-PLOR phasing X-PLOR OMEGA-AGATOXIN IVA OMEGA-AGATOXIN IVA 1 Y N disulf 2.015 A CYS 4 A SG CYS 4 1_555 A CYS 20 A SG CYS 20 1_555 disulf 2.021 A CYS 12 A SG CYS 12 1_555 A CYS 25 A SG CYS 25 1_555 disulf 2.024 A CYS 19 A SG CYS 19 1_555 A CYS 36 A SG CYS 36 1_555 disulf 2.022 A CYS 27 A SG CYS 27 1_555 A CYS 34 A SG CYS 34 1_555 NEUROTOXIN NEUROTOXIN TOG4A_AGEAP UNP 1 1 P30288 KKKCIAKDYGRCKWGGTPCCRGRGCICSIMGTNCECKPRLIMEGLGLA 1 48 1OAV 1 48 P30288 A 1 1 48 3 anti-parallel anti-parallel A GLY 10 A GLY 10 A CYS 12 A CYS 12 A CYS 34 A CYS 34 A LYS 37 A LYS 37 A GLY 24 A GLY 24 A CYS 27 A CYS 27 1 P 1